1V-LSD, or 1-valeryl-LSD, is a novel lysergamide compound chemically derived from LSD-25. It belongs to the family of serotonergic psychedelics and is structurally similar to other well-known analogs such as 1P-LSD and ALD-52. It functions as a prodrug, meaning it is believed to convert into LSD-25 in the human body, producing comparable psychoactive effects. Due to its recent emergence and legal status in various regions, it is often used in scientific research, psychoactive studies, and experimental settings where LSD-25 is restricted.

• Chemical Classification: 1V-LSD is a lysergamide derivative, part of the ergoline family. It shares a core indole ring structure similar to LSD, which gives it its powerful interaction with serotonin receptors.

• Prodrug Activity: Studies and anecdotal reports suggest that 1V-LSD acts as a prodrug to LSD-25, undergoing metabolic transformation in the body to produce effects nearly indistinguishable from LSD.

• Psychoactive Profile: Users report a wide range of effects, including visual distortions, euphoria, introspection, altered sense of time, and heightened sensory perception—closely mimicking the classic LSD experience.

• Research Applications: Its legal availability makes 1V-LSD a valuable tool in neuroscience, psychopharmacology, and consciousness studies, allowing researchers to explore the 5-HT2A receptor pathway and brain network connectivity.

• Legal Alternative to LSD: In regions where LSD is banned, 1V-LSD offers a legally obtainable alternative that delivers similar effects without violating local laws—though users must still consult local regulations.

• Molecular Properties: The addition of a valeryl group at the indole nitrogen distinguishes it from LSD-25. This substitution contributes to its distinct legal and pharmacokinetic behavior while retaining high receptor affinity.

• Subjective Effects: Reports often cite experiences including ego dissolution, synesthesia (seeing sounds or hearing colors), vivid internal visions, and enhanced emotional depth during the experience.

The legality of 1V-LSD is a major factor in its growing popularity, but its legal status varies widely by country and is often subject to rapid change. In many places, 1V-LSD exists in a legal gray area—not specifically listed as a controlled substance, allowing its sale for research or analytical use. However, this status may not be permanent, and anyone purchasing or possessing it should stay updated on local laws.

• Not Scheduled Internationally: As of now, 1V-LSD is not classified under the UN Convention on Psychotropic Substances, allowing its open sale in several jurisdictions for non-consumptive use.

• Legal for Research in the EU: Many European countries permit the sale and possession of 1V-LSD for research or analytical purposes, though laws vary between member states.

• U.S. Legal Gray Area: In the United States, 1V-LSD is not federally scheduled but may fall under the Federal Analog Act if intended for human consumption—making its status ambiguous and risky.

• Country-Specific Bans: Germany classified 1V-LSD as a controlled substance in 2022, and other nations may follow suit. Customers should research their country’s regulatory stance before purchase.

• Safe Harbor for Labs: Institutions and labs registered for chemical handling may acquire 1V-LSD legally under research exemptions in certain regions.

• Vendor Responsibility: At Psycho Plug, we only ship to jurisdictions where 1V-LSD is not explicitly banned. It is the buyer’s responsibility to ensure compliance with their local regulations.

• Regulatory Shifts Possible: As the popularity of 1V-LSD grows, legislation may evolve. Continuous monitoring of legal developments is essential for both vendors and buyers.

Proper storage is critical for preserving the potency, stability, and safety of 1V-LSD over time. Whether in blotter or liquid form, 1V-LSD is sensitive to heat, light, and moisture—conditions that can degrade the compound and reduce its effectiveness. Following optimal storage protocols ensures the product remains stable for months or even years.

• Cool and Dark Environment: Store 1V-LSD in a location away from direct light and heat sources. UV light can break down lysergamides rapidly, so a drawer or fridge is ideal.

• Refrigeration Recommended: For long-term storage, keep 1V-LSD in a sealed container in the refrigerator (not freezer), ideally between 2°C and 8°C. This maintains molecular integrity and minimizes degradation.

• Airtight Packaging: Moisture can destroy 1V-LSD molecules. Always store in airtight bags or containers, preferably with desiccant packs to control humidity.

• Foil-Wrapped Blotters: Blotters should be kept wrapped in foil or sealed in plastic within a dark container. Exposure to air or touch may decrease stability.

• Avoid Frequent Exposure: Opening and closing the storage container repeatedly introduces air and temperature shifts that degrade the substance faster.

• Label Clearly for Safety: Even in personal collections, all containers should be labeled accurately with date, dosage, and compound name to prevent misuse.

1V-LSD produces a wide range of psychoactive effects that are nearly identical to LSD-25. These effects are dose-dependent and influenced by the user’s set (mindset), setting (environment), and physiology. Many users report spiritual, emotional, and cognitive shifts, along with vivid sensory phenomena and altered perception of space and time.

• Visual Hallucinations: Common effects include geometric patterns, vibrant colors, visual breathing, and kaleidoscopic distortions in objects or surroundings.

• Altered Time Perception: Time may appear to slow down, speed up, or lose meaning entirely. A few hours may feel like minutes or vice versa.

• Ego Dissolution: Higher doses can lead to a profound loss of self-identity, where users feel merged with the universe or disconnected from personal boundaries.

• Emotional Amplification: Emotions are often intensified, with users feeling extreme joy, empathy, wonder, or even temporary anxiety depending on their mental state.

• Sensory Enhancement: Music, taste, and tactile sensations may feel more immersive or emotionally charged, making art and nature especially engaging.

• Cognitive Shifts: Thought loops, abstract reasoning, and deep introspection are common. Users often explore philosophical or existential questions.

• Afterglow Effects: Many users report lingering positive effects for hours or even days afterward, including mental clarity, emotional balance, and creative inspiration.

Dosing 1V-LSD correctly is essential for ensuring safe and reliable results, especially in research or experimental settings. Like LSD-25, 1V-LSD is active at microgram levels, making precise dosing critical. The ideal dosage depends on the purpose of use—whether it’s for microdosing, cognitive enhancement, or full psychedelic exploration.

• Microdose (10–25 mcg): Used for cognitive enhancement, mood stabilization, and creativity without perceptual distortion. Taken 2–3 times weekly in cycling protocols.

• Threshold Dose (40–60 mcg): Produces subtle visual enhancement, mild euphoria, and light perceptual shifts. Ideal for beginners or cautious researchers.

• Standard Dose (100–150 mcg): Elicits a full psychedelic experience including vivid visuals, altered cognition, and emotional insight. This is the most common research range.

• High Dose (200–300 mcg): Suitable only for advanced users. May lead to intense ego dissolution, profound visual effects, and extended trips lasting 12+ hours.

• Liquid Dosing: For research flexibility, 1V-LSD liquid can be measured using a microgram-accurate dropper (e.g., 1 drop = 100mcg if diluted accordingly).

• Blotter Consistency: Our blotters are lab-dosed at 100mcg each for reliability. Store them properly to maintain dosing accuracy.

• Always Start Low: If uncertain about sensitivity or prior response, start with half or quarter doses and adjust over time.

When used in a controlled setting with proper dosage, 1V-LSD is generally considered to have a high safety profile, similar to that of LSD-25. While no substance is without risk, 1V-LSD has shown low toxicity, no known overdose deaths, and minimal physiological impact when used responsibly. However, psychological effects can be profound, especially at high doses, and must be approached with caution.

• Low Physiological Toxicity: 1V-LSD has not been linked to organ damage or physical harm at standard research doses. It does not appear to cause neurotoxicity or tissue damage in current research.

• No Lethal Dose Established: There are no documented fatalities from isolated 1V-LSD use. Animal studies and human reports indicate an extremely high threshold for toxicity.

• Non-Addictive Profile: 1V-LSD, like LSD-25, does not cause chemical dependence or withdrawal symptoms. There’s no documented addictive behavior associated with its use.

• Psychological Risks Exist: At high doses or in unstable settings, users may experience panic, paranoia, or temporary psychosis. This is typically resolved without long-term harm, but caution is advised.

• Set and Setting Are Critical: The user’s mindset and environment have a major influence on safety. A calm, safe, and supportive setting dramatically reduces the risk of adverse psychological effects.

• Pre-existing Mental Health Conditions: Individuals with schizophrenia, bipolar disorder, or other psychiatric vulnerabilities are strongly advised not to use 1V-LSD, as it can trigger episodes.

• Safe Use Requires Preparation: Having a sober sitter, staying hydrated, and avoiding other substances (especially alcohol or stimulants) enhances both safety and experience quality.

The duration of 1V-LSD’s effects is similar to LSD-25, generally lasting between 8 to 12 hours depending on dose, individual metabolism, and method of administration. While the core psychedelic effects taper off within 10–12 hours, residual sensations and emotional insights may continue well into the next day.

• Onset Phase (30–90 minutes): This period includes initial body sensations, slight visual enhancement, and mood changes. It’s often subtle but can include some anxiety as the trip begins.

• Peak Effects (2–6 hours): Most intense visual, emotional, and cognitive alterations occur during this time. Perception of time, ego boundaries, and sensory input are significantly altered.

• Plateau Phase (6–8 hours): Effects stabilize, and the experience becomes more introspective. Visuals fade slightly, but emotional and cognitive shifts continue.

• Comedown (8–12 hours): Psychedelic effects diminish, energy returns to baseline, and the user begins to reorient to their normal state. Fatigue is common during this phase.

• Afterglow (12–24 hours): A state of clarity, emotional openness, and residual insight may linger. Many report this phase as calming, even euphoric.

• Duration Varies with Dose: Higher doses tend to prolong each phase, especially the peak and comedown. Lower doses shorten the overall experience.

• Individual Factors Matter: Body weight, liver metabolism, hydration, and even sleep quality can influence the speed and intensity of each phase.

While 1V-LSD and LSD-25 are nearly identical in terms of subjective effects, they differ in chemical structure, legal classification, and pharmacokinetics. 1V-LSD was developed as a legal analog of LSD-25 and is structurally modified to bypass scheduling laws in many jurisdictions, yet it still delivers a comparable psychedelic experience.

• Chemical Structure: 1V-LSD has a valeryl group attached to the indole nitrogen of the lysergamide backbone. This structural change makes it legally distinct from LSD-25 but allows it to act as a prodrug.

• Prodrug Behavior: Once ingested, 1V-LSD is believed to metabolize into LSD-25, which is responsible for most of its psychoactive effects. This is similar to other analogs like 1P-LSD and ALD-52.

• Legal Status: LSD-25 is globally controlled and illegal in most jurisdictions. In contrast, 1V-LSD is unregulated in several regions and legally sold for research or analytical purposes.

• Onset and Duration Differences: Some users report a slightly slower onset and milder peak with 1V-LSD, although this is subjective and varies by dose and individual metabolism.

• Subjective Experience: The overall trip is almost indistinguishable from LSD-25, with deep visuals, introspection, and emotional elevation. Subtle variations may exist but are minimal.

• Availability and Accessibility: 1V-LSD is more readily available online, often without prescription, while LSD-25 is rarely sold legally outside of clinical studies.

• Research Focus: 1V-LSD is gaining popularity among labs and academic institutions because it offers a legal alternative for studying serotonin agonism and altered states.

Standard drug tests used in employment, law enforcement, or athletics typically do not screen for lysergamide compounds like 1V-LSD. However, some advanced or forensic-level tests may be able to detect it or its metabolites under specific conditions. Detection depends largely on the type of test, sensitivity, and purpose.

• Not Detected in Standard Panels: Routine drug screenings (5-panel or 10-panel tests) do not include LSD or its analogs like 1V-LSD. These tests target opioids, cannabinoids, amphetamines, and similar substances.

• Requires Specialized Testing: Detection of 1V-LSD would require highly sensitive tests like gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–mass spectrometry (LC-MS), which are rarely used outside forensic labs.

• Short Detection Window: Even if tested, lysergamides like LSD and 1V-LSD are typically detectable for only 24–72 hours after ingestion, as they are rapidly metabolized and excreted.

• LSD-25 Metabolite Overlap: Because 1V-LSD is a prodrug of LSD-25, some of the resulting metabolites may be similar to those produced by LSD. This could theoretically trigger a positive in highly specific LSD tests.

• No Known False Positives: There is no current evidence suggesting that 1V-LSD causes false positives in standard workplace testing protocols.

• Athletic or Military Testing: Some elite sports organizations or military branches may conduct extended drug panels. Caution is advised in these environments.

We offer 1V-LSD in both blotter and liquid form to accommodate various research and dosing preferences. Each format is produced under sterile lab conditions, precisely measured, and sealed to maintain potency. The form you choose depends on your dosing method, storage needs, and experimental requirements.

• Blotter Form: These are small squares of perforated paper dosed with 100 micrograms each. They are convenient, portable, and ideal for microdosing or controlled dose trials.

• Liquid Form: Delivered in dark glass dropper bottles, each milliliter contains 1,000 micrograms (1mg) of 1V-LSD. This allows for flexible titration using precise droppers.

• Carrier Solvents: Our liquid 1V-LSD is suspended in high-purity ethanol or distilled water for stability. Solvent type is clearly listed on the product label.

• Measured Accuracy: Both formats are verified via third-party lab analysis to ensure dosing accuracy, consistency, and purity at ≥99.5%.

• Discreet Packaging: Regardless of format, all orders are shipped in tamper-proof, nondescript packaging with no external markings.

• Storage Differences: Blotters are easier to store and transport discreetly, while liquid offers more flexibility for custom research protocols.

• Labeling and Documentation: Each unit comes with batch-specific data including dosage, expiration date, and QR codes linking to purity analysis results.

1V-LSD, much like LSD-25, is known for its profound effects on cognitive functioning. It enhances pattern recognition, abstract thinking, and associative memory. These cognitive shifts are often sought after in research on creativity, problem-solving, and mental flexibility. While not a nootropic in the conventional sense, 1V-LSD has drawn attention for its ability to stimulate non-linear thinking and introspective insight.

• Enhanced Pattern Recognition: Many users report a heightened ability to detect connections between ideas, systems, or concepts. This is particularly noticeable in visual or auditory fields, such as art or music.

• Improved Associative Thinking: 1V-LSD facilitates associative memory and idea generation. Thoughts often flow more fluidly, and seemingly unrelated concepts can become meaningfully linked.

• Expanded Perspective-Taking: The compound may allow users to examine beliefs or problems from multiple angles, leading to more flexible thinking and novel insights.

• Disruption of Default Mode Network (DMN): 1V-LSD decreases activity in the brain’s DMN, the network associated with self-referential thoughts. This can reduce rigid thought patterns and support cognitive exploration.

• Access to Subconscious Material: Individuals often recall forgotten memories or access emotional or psychological content normally buried in the subconscious.

• Transient Thought Loops: While beneficial in moderate doses, higher doses can cause looping thoughts that may impair logical reasoning or become frustrating without proper grounding.

• Potential for Creative Insight: Artists, writers, and scientists have historically used lysergamides like 1V-LSD to stimulate innovation, reflection, and creative breakthroughs.

Combining 1V-LSD with other substances carries additional risks and should only be approached with caution, if at all. While some combinations may be sought for synergistic or balancing effects, many introduce complications due to unpredictable interactions, especially involving the serotonin system. Researchers and users must be fully informed before considering any form of poly-substance use.

• SSRI and Antidepressants: Selective serotonin reuptake inhibitors (SSRIs) can dampen or completely block the effects of 1V-LSD. There is also a small but serious risk of serotonin syndrome if combined with certain antidepressants like MAOIs or SNRIs.

• Alcohol: Alcohol may dull the psychedelic experience and increase the likelihood of nausea, dehydration, and poor decision-making. It also impairs memory formation during the trip.

• Cannabis: Cannabis can intensify visual and emotional effects when combined with 1V-LSD. However, it can also increase anxiety or paranoia, especially during the come-up or comedown.

• Benzodiazepines: These are sometimes used to abort or soften the trip during intense moments, but they also suppress valuable cognitive and emotional processing. Dependency risks exist with prolonged use.

• Stimulants (e.g., Adderall, Cocaine): These can dangerously elevate heart rate and blood pressure when combined with 1V-LSD, significantly increasing physical and psychological stress.

• MDMA (Candyflipping): Combining 1V-LSD with MDMA is known as “candyflipping.” While it can enhance emotional connection and euphoria, it also elevates neurotoxicity and physical risk due to overstimulation.

• Ketamine or Dissociatives: These combinations can lead to intense ego disconnection or confusion. While used in experimental psychotherapy, they require professional supervision.

Traveling with 1V-LSD, whether domestically or internationally, poses significant legal and logistical risks, even in jurisdictions where the compound may not be scheduled. Border authorities, customs officials, and airline security may treat it as contraband based on local analog laws or simple suspicion. We strongly advise against carrying 1V-LSD during travel unless fully authorized and legally compliant.

• Legal Risk at Borders: Even if 1V-LSD is legal in your country, it may be treated as an LSD analog and result in seizure or arrest when crossing borders.

• Customs Confiscation: Packages or personal items found to contain 1V-LSD may be seized without refund, and you could be subject to fines or investigation.

• Possession Without Documentation: Without official lab or research credentials, carrying 1V-LSD can appear suspicious and lead to legal trouble even in legally gray areas.

• Air Travel Restrictions: Airport scanners and sniffer dogs may detect packaging or substances, especially in liquid form. Law enforcement does not distinguish between analogs and controlled substances.

• Country-Specific Bans: Some countries, such as Germany and Japan, have outright banned 1V-LSD. Traveling to or through these countries with the compound is a criminal offense.

• Mail Forwarding as Alternative: If you must use 1V-LSD in a different region for research, consider using a secure mail forwarding service in compliance with local import laws.

• Stealth Does Not Equal Safety: Discreet transport is not a legal defense. If caught, you may face drug charges regardless of intent or personal use.

1V-LSD has quickly become a leading choice for scientific and exploratory research due to its structural similarity to LSD-25, legal availability in many jurisdictions, and reliable psychoactive profile. Its predictability and potency make it an ideal compound for studies on consciousness, serotonin receptors, and altered cognitive states.

• Legal Accessibility: In jurisdictions where LSD-25 is banned, 1V-LSD offers a viable legal alternative for conducting serotonergic research and consciousness studies.

• Pharmacological Similarity to LSD-25: As a prodrug, 1V-LSD converts into LSD in the body, making it a reliable substitute for LSD in pharmacokinetic and neurobiological research.

• Predictable Dosage and Response: Our lab-tested 1V-LSD has a consistent potency, allowing researchers to perform repeated trials with uniform results.

• Well-Tolerated by Subjects: Anecdotal and preliminary reports indicate that 1V-LSD is physiologically benign, making it suitable for human trials where permitted.

• Valuable for Microdosing Studies: Increasing interest in microdosing for mood, cognition, and productivity has led researchers to use 1V-LSD due to its legal status and effectiveness at low doses.

• Reduced Bureaucratic Burden: Because it is unscheduled in many regions, researchers can obtain 1V-LSD without lengthy approval processes required for Schedule I substances.

• Compatible with Neuroimaging: Studies using fMRI and EEG have begun to examine the brain under the influence of lysergamide analogs like 1V-LSD, providing insight into network connectivity and consciousness.

Ensuring the purity of 1V-LSD is essential for safe use in research, and at Psycho Plug, we uphold the highest standards of chemical verification. Each batch of 1V-LSD undergoes rigorous laboratory analysis to confirm its identity, potency, and freedom from contaminants. Our purity standards meet or exceed those used in pharmaceutical and research-grade testing.

• HPLC (High-Performance Liquid Chromatography): This method accurately separates and quantifies the components of a compound. It is used to verify that the sample contains ≥99.5% 1V-LSD.

• GC-MS (Gas Chromatography–Mass Spectrometry): Used to detect even trace impurities, GC-MS provides a detailed molecular fingerprint of the compound.

• NMR (Nuclear Magnetic Resonance) Spectroscopy: This technique verifies the molecular structure and ensures that no isomers or unwanted byproducts are present.

• COA (Certificate of Analysis): Each batch is accompanied by a Certificate of Analysis from an independent lab, confirming purity, concentration, and compound identity.

• Microbial and Solvent Screening: All batches are tested for residual solvents, heavy metals, and microbial contamination to ensure full compliance with research safety standards.

• Consistent Batch Numbers: Each unit is labeled with a unique batch number and QR code, linking it to its specific purity and origin data.

• Third-Party Verification: We use internationally accredited labs that meet ISO/IEC 17025 standards to provide unbiased and reproducible testing results.